Skip to content
California Healthline California Healthline California Healthline
  • Republish Our Content
  • Email Sign Up
  • Contact Us
  • Connect With Us:
  • Contact
  • Twitter
  • Facebook
  • RSS
  • Daily Edition
  • Special Reports
    • Homeless Crisis
    • Medi-Cal Makeover
    • Industry Influence
    • Public Health Watch
  • Faces of Medi-Cal
  • Noticias En Español
  • More Topics
    • Aging
    • Asking Never Hurts
    • Audio Report
    • Covid
    • Health Industry
    • Insurance
    • Medi-Cal
    • Medicare
    • Mental Health
    • Spotlight

Search Results

Filter Results

Reset filters
Date
Custom Date Range
Topic
Content Type

Showing 11-20 of 261 results for "Shefali Luthra"

Sort by

KFF Health News' 'What the Health?': Trump Further Politicizes Science

August 14, 2025

President Donald Trump’s latest executive order about science and medicine seeks to take funding decisions out of the hands of career scientists and give them to political appointees instead. And a gunman, reportedly disgruntled over covid vaccines, shoots at the headquarters of the Centers for Disease Control and Prevention, killing a law enforcement officer. Alice Miranda Ollstein of Politico, Shefali Luthra of The 19th, and Sarah Karlin-Smith of the Pink Sheet join KFF Health News’ Julie Rovner to discuss these stories and more. Also this week, Rovner interviews Aaron Carroll, president and CEO of the health services research group AcademyHealth, about how to restore the public’s trust in public health.

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to share on X (Opens in new window) X
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

KFF Health News' 'What the Health?': American Health Under Trump — Past, Present, and Future

September 19, 2024

Dreaming of a Trump victory, Republicans have a wish list of health policy changes — including loosening Affordable Care Act regulations to make cheaper coverage available and ending Medicare drug price negotiations. Meanwhile, after a publicly reported death stemming from a state abortion ban, Vice President Kamala Harris is emphasizing the consequences of Trump’s work to overturn Roe v. Wade. Tami Luhby of CNN, Shefali Luthra of The 19th, and Joanne Kenen of Politico and Johns Hopkins University join KFF Health News senior editor Emmarie Huetteman to discuss these stories and more.

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to share on X (Opens in new window) X
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

KFF Health News' 'What the Health?': The Cutting Continues

March 13, 2025

The Trump administration’s efforts to downsize the federal government continue, with both personnel and programs being cut at the Department of Health and Human Services, the Department of Veterans Affairs, and the Social Security Administration. Meanwhile, the fight over cuts to the Medicaid program for those with low incomes heats up, as Republicans worry that more of their voters than ever before are Medicaid beneficiaries. Alice Miranda Ollstein of Politico, Shefali Luthra of The 19th, and Anna Edney of Bloomberg News join KFF Health News’ Julie Rovner to discuss these stories and more. Also this week, Rovner interviews Jeff Grant, who recently retired from the Centers for Medicare and Medicaid Services after 41 years in government service.

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to share on X (Opens in new window) X
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

KFF Health News' 'What the Health?': Anti-Abortion Hard-Liners Speak Up

May 23, 2024

While Republican candidates in many states downplay their opposition to abortion, the most vehement wing of the movement, which helped overturn Roe v. Wade — those who advocate prosecuting patients, outlawing contraception, and banning IVF — are increasingly outspoken. Meanwhile, some state legislatures continue to advance new restrictions, like a proposal moving in Louisiana to include abortion medications mifepristone and misoprostol on the list of the most dangerous drugs. Alice Miranda Ollstein of Politico, Rachel Roubein of The Washington Post, and Joanne Kenen of the Johns Hopkins schools of public health and nursing and Politico Magazine join KFF Health News’ Julie Rovner to discuss these stories and more. Also this week, Rovner interviews Shefali Luthra of The 19th about her new book on abortion in post-Roe America, “Undue Burden.”

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to share on X (Opens in new window) X
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

KFF Health News' 'What the Health?': Let the General Election Commence

August 23, 2024

Abortion and reproductive health issues headlined the Democratic National Convention in Chicago, as expected. But what Vice President Kamala Harris has in mind for other health policies as the Democratic nominee remains something of a mystery. Meanwhile, former President Donald Trump says he would not use the 19th-century Comstock Act to impose, in effect, a national ban on abortion, which angered his anti-abortion backers. Alice Miranda Ollstein of Politico, Joanne Kenen of Politico and Johns Hopkins University, and Shefali Luthra of The 19th join KFF Health News’ Julie Rovner to discuss these stories and more. Also this week, Rovner interviews KFF Health News’ Tony Leys, who reported and wrote the latest KFF Health News-NPR “Bill of the Month” feature about a woman who fought back after being charged for two surgeries despite undergoing only one.

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to share on X (Opens in new window) X
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

KFF Health News' 'What the Health?': GOP Platform Muddies Abortion Waters

July 11, 2024

As Donald Trump prepares to be formally nominated as the GOP’s candidate for president next week, the platform he will run on is taking shape. And in line with Trump’s approach, it aims to simultaneously satisfy hard-core abortion opponents and reassure more moderate swing voters. Meanwhile, the Federal Trade Commission takes on pharmacy benefits management firms. Shefali Luthra of The 19th News, Sandhya Raman of CQ Roll Call, and Jessie Hellmann of CQ Roll Call join KFF Health News’ chief Washington correspondent, Julie Rovner, to discuss these stories and more. Also this week, Rovner interviews Jennifer Klein, director of the White House Gender Policy Council, about the Biden administration’s policies to ensure access to reproductive health care.

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to share on X (Opens in new window) X
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

KFF Health News' 'What the Health?': New Year, Same Abortion Debate

January 4, 2024

Some Supreme Court justices were wrong if they assumed overturning “Roe v. Wade” would settle the abortion issue before the high court. At least two cases are awaiting consideration, and more are in the legal pipeline. Meanwhile, Congress once again has only days until the next temporary spending bill runs out, with no budget deal in sight. Lauren Weber of The Washington Post, Shefali Luthra of The 19th, and Victoria Knight of Axios join KFF Health News chief Washington correspondent Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Sandro Galea, dean of the Boston University School of Public Health, about how public health can regain public trust.

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to share on X (Opens in new window) X
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

KFF Health News' 'What the Health?': Abortion Pill’s Legal Limbo Continues

August 17, 2023

A federal appeals court issued a split decision on whether the abortion pill mifepristone should remain on the market — rejecting a lower court’s decision to effectively cancel the drug’s FDA approval in 2000, while ordering the rollback of more recent rules that made the drug easier to obtain. Nothing changes immediately, however, as the Supreme Court blocked the lower court’s ruling in the spring. It will be up to the high court to determine whether the pill remains available in the U.S. and under which conditions. Sarah Karlin-Smith of the Pink Sheet, Alice Miranda Ollstein of Politico, and Shefali Luthra of The 19th join KFF Health News’ chief Washington correspondent, Julie Rovner, to discuss these issues and more. Plus, for “extra credit,” the panelists suggest health policy stories they read this week they think you should read, too.

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to share on X (Opens in new window) X
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

KFF Health News' 'What the Health?': The Confusing Fate of the Abortion Pill

April 13, 2023

The legality and availability of the abortion pill mifepristone is in question after a federal judge in Texas canceled the FDA’s approval of the first drug used in the two-drug medication abortion regimen. A 5th Circuit Court of Appeals panel overruled that decision in part, saying the pill should remain available, but only under the onerous restrictions in place before 2016. Meanwhile, another federal judge in Washington state issued a ruling in a separate case that conflicts with the Texas decision, ordering the FDA not to roll back any of its restrictions on the drug. Victoria Knight of Axios, Shefali Luthra of The 19th, and Sarah Karlin-Smith of the Pink Sheet join KFF Health News chief Washington correspondent Julie Rovner to discuss these issues and more.

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to share on X (Opens in new window) X
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

KFF Health News' 'What the Health?': Dancing Under the Debt Ceiling

April 27, 2023

House Republicans passed their plan to raise the nation’s debt ceiling, along with major cuts to health (and other domestic) programs. Unlikely to become law, it calls for new work requirements for adults on Medicaid. Meanwhile, state efforts targeting trans people bear a striking resemblance to the fight against abortion rights. Jessie Hellmann of CQ Roll Call, Shefali Luthra of The 19th, and Sarah Karlin-Smith of the Pink Sheet join KFF Health News chief Washington correspondent Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Renuka Rayasam, who reported the latest KFF Health News-NPR “Bill of the Month” feature, about a specialist’s demand to be paid as much as $15,000 before treating a woman’s serious pregnancy complication.

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to share on X (Opens in new window) X
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
  • Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next

From The California Health Care Foundation

Insurance Data Health Insurers Enrollment Almanac — 2025 Edition

The latest data shows that California health insurers covered 36.2 million people. See a breakdown of enrollment by regulator, market, and insurer, and access historical data.

The Latest on CalAIM Reforms

CalAIM has the potential to improve health outcomes for millions of people enrolled in Medi-Cal. Track the latest developments and insights on this multi-year reform effort.

Behavioral Health California's Behavioral Health Data Landscape

As the state embarks on a significant overhaul, this report captures the current state of behavioral health data collection. See how it currently measures quality and outcomes, as well as future directions for the system.

California Healthline

© California Healthline 1998-2025. All Rights Reserved.

California Healthline is a service of the California Health Care Foundation produced by KFF Health News, an editorially independent program of the KFF.

  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Staff
  • Republish Our Content
  • Email Sign-Up
  • Twitter
  • Facebook
  • RSS

Powered by WordPress VIP